glp-1 impact on bariatric surgery vs Medications for Long-Term Weight Loss GLP-1 for Weight Loss and

GLP-1 receptor agonists are peptide drugs cleared through proteolytic cleavage essentially broken down by the same enzymatic processes that digest dietary protein

In the series of 11 clinical trials (SUSTAIN programme) GLP-1 agonists demonstrated improved glycemic control in patients with diabetes (as measured by HbA1c) but also showed a consistent weight loss in trial participants

Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients

Therefore, treatment capable of reducing synovial inflammation and slowing down cartilage destruction should have the essential characteristics of disease-modifying OA drugs (DMOADs)